Seoul Seeks To Expand Biomedical Fund With MOUs Signed With U.S. States Massachusetts And Maryland
This article was originally published in PharmAsia News
Executive Summary
SEOUL - The Seoul Metropolitan Government is pushing to expand its KRW 100 billion ($92.2 million) biomedical fund, established last year by the Boston venture capital firm Oxford Bioscience Partners and Korea's Hanwha Venture Capital to boost Korea's life sciences industries
You may also be interested in...
Korea's Medical Tourism Push Can Benefit Korean And Global Pharma - Medical Korea 2011
SEOUL - South Korea's bid to top Thailand, India and Singapore as an Asian hub for healthcare services, particularly medical tourism, should be beneficial to both Korean and global pharmas, Seoul officials said
Korea Expects MOU with Cigna To Attract More Medical Tourism Patients, Possibly From China - Medical Korea 2011 Conference
SEOUL - South Korea expects to sign an MOU with Cigna International next month as part of its efforts to establish Korea as an attractive medical tourism destination, Kim Bup-wan, president of the Korea Health Industry Development Institute told local reporters
Korea Signs Healthcare MOU With UAE; Seeks Out More Global Partners To Draw Medical Tourism To Korea
SEOUL - South Korea's Ministry of Health and Welfare has signed a memorandum of understanding with the United Arab Emirates to bring the latter's patients into Korea for medical treatments not available in UAE